Adis Journals
2 files

Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study

posted on 2021-04-13, 14:27 authored by Adis journals on behalf of, Philip J. Mease, Apinya Lertratanakul, Kim A. Papp, Filip E. van den Bosch, Shigeyoshi Tsuji, Eva Dokoupilova, Mauro W. Keiserman, Xianwei Bu, Liang Chen, Reva M. McCaskill, Patrick Zueger, Erin L. McDearmon-Blondell, Aileen L. Pangan, William Tillett

Article full text

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2021.


Usage metrics

    Rheumatology and Therapy